1. Analysis of 25I-NBOMe, 25B-NBOMe, 25C-NBOMe and other dimethoxyphenyl-N-[(2-Methoxyphenyl) methyl]ethanamine derivatives on blotter paper;Poklis;J. Anal. Toxicol.,2015
2. Characterization of eleven 2,5-dimethoxy-N-(2-methoxybenzyl)phenethylamine (NBOMe) derivatives and differentiation from their 3- and 4-methoxybenzyl analogues – Part I;Casale;Microgram,2012
3. 2-(4-Iodo-2,5-dimethoxyphenyl)-N-[(2-methoxyphenyl)methyl]ethanamine (25I-NBOMe): clinical case with unique confirmatory testing;Stellpflug;J. Med. Toxicol.,2014
4. Schedules of Controlled Substances: Placement of Three Synthetic Phenethylamines Into Schedule I, Fed. Reg., Drug Enforcement Administration, 2013.
5. Schedules of Controlled Substances: Extension of Temporary Placement of Three Synthetic Phenethylamines in Schedule I. Final order., Fed. Regist., Drug Enforcement Administration, 2015.